INTRODUCTION
Infection with human immunodeficiency virus type 1 (HIV-1) is dependent on interaction between the external viral envelope glycoprotein gp120 and CD4/appropriate chemokine coreceptor (Horuk, 1999) . This association is also required for virus-mediated syncytium formation (Barbeau et al., 1998; Lifson et al., 1986a,b) . Although this high-affinity interaction appears to be sufficient under certain conditions, other factors, including the degree of sialylation (i.e., sialic acid content) of glycoconjugates on the surface of virions and/or target cells, have been suggested as influencing the extent of viral replication (Hu et al., 1996; Stamatos et al., 1997) .
Monosaccharides such as sialic acids are transferred onto glycolipids and membrane/secretory molecules when they reach the trans-Golgi apparatus, which represents the terminal port of the secretory pathway (Keppler et al., 1999; Taylor, 1996) . One of the distinct features of sialic acid is the net negative charge that it adds to the overall cell surface. In fact, removal of sialic acid residues from cell surface proteins results in higher cell-tocell contact, presumably by enhancing protein-protein interactions through reduction of the net negative surface charge (Acheson et al., 1991; Rutishauser et al., 1985) . The degree of sialylation is determined and regulated by the balance between the activities of several different sialyltransferases and sialidases. Neuraminidase (NA), or sialidase, is an enzyme catalyzing the removal of sialic acid residues from various glycoconjugates. In animals, neuraminidases have been located in almost every tissue, where the enzymes fulfill various roles by regulating the surface sialic acid profile of cells. It is clear that NA activity regulates certain cellular processes, since sialic acid content has been reported to be of importance for cell-cell interaction, T and B cell activation, and hematopoietic cell differentiation (Keppler et al., 1999; Taylor, 1996) .
Several bacteria, parasites and viruses produce sialidases as virulence factors that can be expressed under two distinct forms, either expressed on their surface or secreted into the surrounding environment (Taylor, 1996) . Interestingly, some of these pathogens are recognized as opportunistic agents in the course of AIDS. For example, Streptococcus, Pneumococcus, Bacteroides, Actinomyces, Pseudomonas aeruginosa, Trypanosoma cruzi, Cryptosporidium parvum, and Pneumocystis carinii are considered opportunist agents in HIV-1-infected individuals and these pathogens produce sialidases that have been implicated as virulence factors (Taylor, 1996) . Lymph nodes are the preferential sites in which microbial agents are concentrated during the normal immune response and in which a concomitantly high level of HIV-1 replication is thought to occur (Graziosi et al., 1998; Pantaleo et al., 1991; Poli et al., 1993) . Therefore, it is likely that high levels of pathogen-derived NA will be present in secondary lymphoid organs such as lymph nodes. Thus, it is important to investigate the role of pathogen-derived NA in the course of HIV-1 infection, as a better understanding of putative risk factors may lead the way to novel therapeutic strategies to control this retroviral disease. The extent of sialylation has been postulated to modulate the capacity of HIV-1 to interact with susceptible T cells. Initial studies showed that treatment of HIV-1 with NA renders virus particles more infectious (Hu et al., 1996) , and the use of NA has been reported to greatly improve HIV-1 isolation from peripheral blood mononuclear cells (PBMCs) originating from infected individuals (Xin et al., 1998) . Moreover, treatment of PBMCs with NA was found to promote HIV-1 replication (Stamatos et al., 1997) . However, the exact mechanism responsible for NA-mediated enhancement of viral growth is still obscure. Interestingly, infectivity of simian immunodeficiency virus was recently shown to be affected by sialic acid residues (Means and Desrosiers, 2000) .
In this report, we have tested the modulatory role of NA on HIV-1-mediated syncytium formation and found higher levels of cell-to-cell conjugate formation in the presence of Arthrobacter ureafaciens-derived NA. We have also noticed that desialylation of both virions and target cells markedly increased HIV-1 replication through an augmentation of the initial steps of the virus life cycle, namely the binding and entry processes. Our data suggest that microbial pathogens bearing neuraminidases might then be considered as cofactors in the pathogenesis of HIV-1 infection.
RESULTS
The presence of bacterial-derived NA induced a significant increase in HIV-1-dependent syncytium formation CD4-expressing T lymphoid cell lines 1G5 and Jurkat E6.1 were mixed at a 2:1 ratio with chronically HIV-1infected J1.1 cells for 16 h in the presence of Arthrobacter-derived NA. As presented in Fig. 1 , higher levels of cell aggregation were observed when NA was added to the 1G5/J1.1 (Fig. 1A) or the Jurkat/J1.1 (Fig. 1B ) cell mixture. Concomitant with an increase in homotypic cellular aggregation, we noticed a marked increase both in the number and in the size of formed syncytia in the presence of NA. A similar observation was made following treatment of PHA/IL-2-stimulated PBMCs and J1.1 cells with Arthrobacter-derived NA (Fig. 1C) .
Given that measurement of cell-to-cell conjugate formation by visualization with a microscope is not entirely quantitative, our next series of experiments was performed using our previously described luciferase-based quantitative syncytium assay (Barbeau et al., 1998) . To this end, 1G5 cells that stably harbor HIV-1 Long Terminal Repeat (LTR)-driven luciferase constructs were coincubated along with J1.1 in the absence or the presence of Arthrobacter-derived NA. Treatment of the 1G5/J1.1 cell mixture with 0.01 U/ml NA from Arthrobacter led to a 2-fold increase in HIV-1 LTR-dependent gene activity at only 4 h after initiation of coculture ( Fig. 2A ). This increase was more pronounced when incubation was allowed to proceed for 12 and 24 h (6.9 and 8.8-fold increase, respectively). A dose-dependent upregulation of HIV-1 LTR-mediated luciferase activity was seen following treatment of 1G5/J1.1 cells with increasing concentrations of NA (Fig. 2B ). The enzymatic activity of NA was found to be required for the observed increase in virus-dependent syncytium formation since heat-inactivated NA (100°C for 10 min) had no modulating effect on HIV-1-mediated multinucleated giant cell formation ( Fig.  2B ). In an attempt to define whether the NA-induced increase in syncytium formation could be influenced to some extent by the nature of the cell fusion partner and/or virus strain, similar types of assays were next performed by using different human lymphoid T cell lines. Virus-mediated syncytium formation was also enhanced in the presence of NA when 1G5 cells were incubated with other chronically HIV-1-infected cell lines, including H9/HIV-1 IIIB , H9/HIV-1 IIIMN , and H9/HIV-1 IIIRF (Fig.  2C ). Sup-T1 cells transiently transfected with the pLTR-LUC vector cocultured with J1.1 cells in the presence of Arthrobacter-derived NA also resulted in an increase of syncytium formation (Fig. 2D ). Incubation of either transfected Sup-T1 or 1G5 cells alone with NA did not lead to an increase in HIV-1 LTR-driven gene activity, suggesting that NA by itself did not modulate HIV-1 transcription. The sum of these experiments indicated that NA-induced cellular desialylation of human T cells results in a higher rate of HIV-1-induced syncytium formation that is neither cell line-nor viral type-specific, at least for X4 T-tropic isolates of HIV-1.
Next, we defined whether the NA-mediated increase in syncytium formation could alter the inhibitory activity of known blockers of gp120 and CD4/chemokine coreceptor interaction. This goal was achieved by using the anti-CD4 SIM.2 antibody and stromal cell-derived factor 1 (SDF-1), the natural ligand of CXCR4. The rationale for using these two agents was founded on the observation of their potency in abolishing HIV-1-mediated syncytium formation (indicated in previous work) in our assay (Barbeau et al., 1998) . These inhibitory agents almost com-pletely reduced HIV-1 LTR-driven reporter gene expression to similar levels in the absence or the presence of NA (Fig. 3) . These data suggest that the NA-mediated increase in syncytium formation is also dependent on the primary interaction between gp120 and CD4/chemokine coreceptor.
Both gp120-expressing and CD4-positive uninfected cells are the targets of NA action
In order to establish whether gp120-positive or CD4expressing human T cells represent the target of NA, we compared HIV-1 LTR-dependent reporter gene activity, which is a direct reflection of syncytium formation, fol-lowing treatment of J1.1 and/or 1G5 cells with 0.01 U/ml of Arthrobacter-derived NA. To minimize the effect of NA in the subsequent process, excess enzyme was removed by extensive washings of NA-treated cells with ice-cold PBS. Treatment of J1.1 cells alone resulted in a slight but significant increase in HIV-1-dependent syncytium formation upon coculture with 1G5. However, a more pronounced induction was measured when 1G5 cells were instead treated with NA ( Fig. 4 ). The maximal increase in HIV-1-mediated syncytium formation was nonetheless observed when both cell fusion partners were treated with NA, suggesting that desialylation of both gp120positive and CD4-expressing uninfected human T cells contributes to the NA-mediated enhancement of syncytium formation.
Susceptibility of target cells to infection with pseudotyped virions bearing HIV-1, A-MLV, or VSV-G envelope glycoprotein is enhanced by NA-mediated desialylation
To investigate whether NA can also affect the process of single-round virus infection, experiments were conducted using Jurkat cells and HXB-LUC, a recombinant luciferase-encoding T-cell-line-adapted X4 strain of HIV-1. The enzyme treatment was initially done at 37°C for 120 min. Pretreatment of either target cells or virions with 0.01 U/ml of purified Arthrobacter-derived NA led to an increase in the process of virus infection (Fig. 5A ). Pretreament of both entities (i.e., virions and target cells) with NA resulted in a maximal potentiating effect on virus infection, which correlated well with the results obtained in the HIV-1-dependent syncytium formation assay.
Cells derived from the monocyte/macrophage lineage are considered crucial targets for virus infectivity and propagation because, in contrast to viral replication in CD4 ϩ T lymphocytes, these cells are relatively refractory to HIV-1-mediated cytopathic effects. With this in mind,
FIG. 2.
Quantitative determination of NA-mediated enhancement of HIV-1-dependent syncytium formation. (A) 1G5 and J1.1 cells were cocultured at a 2:1 ratio in the absence or presence of Arthrobacter-derived NA (0.01 U/ml) for 4, 6, 8, 12, and 24 h at 37°C. (B) An 1G5/J1.1 cell mixture was incubated for 16 h at 37°C with increasing concentrations of either untreated or heat-inactivated Arthrobacter-derived NA (0.01, 0.05, and 0.1 U/ml). (C) 1G5 and H9 cells chronically infected with HIV-1 IIIRF , HIV-1 IIIMN , or HIV-1 IIIB were cocultured at a 2:1 ratio in the absence or presence of Arthrobacter-derived NA (0.01 U/ml) for 16 h at 37°C. (D) Sup-T1 cells, transiently transfected with a HIV-1 LTR-driven luciferase construct, were cocultured with J1.1 cells at a 2:1 ratio in the absence or presence of Arthrobacter-derived NA (0.01 U/ml) for 16 h at 37°C. Cells were next lysed and luciferase activity was measured with a microplate luminometer. Presented results are the means Ϯ SD of samples carried out in quadruplicate.
we next examined the effect of NA on the process of virus infection on cells of the monocytic lineage. The human monocytoid Mono Mac 1 cell line was thus used, being susceptible to infection by both T-(X4) and macrophage-tropic (R5) stains of HIV-1 (Genois et al., 2000) . Mono Mac 1 cells were pretreated with or without Arthrobacter-derived NA for different time periods (i.e., 30, 60, and 120 min) and then infected with infectious HXB-LUC particles. The enzyme treatment of Mono Mac 1 cells remarkably enhanced the process of virus infection in monocytic cells, as indicated by the four-to fivefold increase in virus-encoded luciferase activity ( Fig. 5B) . Similarly, enhanced infection of Mono Mac 1 cells with HIV-1 was also seen when using virions pseudotyped with the envelope protein from the primary macrophagetropic BaL isolate ( Fig. 5C ). Our findings indicate that infection of human T and monocytoid cells with T-and macrophage-tropic strains of HIV-1 is positively affected by the enzyme treatment and that the NA-mediated effect is rapidly taking place (i.e., in 30 min or less).
There is strong evidence to support the notion that HIV-1 particles enter susceptible cells by direct fusion with the cell membrane. We thus next attempted to define whether NA treatment could still upregulate the process of infection with viruses that can also enter target cells by direct fusion but through a CD4/chemokine coreceptor-independent pathway. For this purpose, Jurkat cells were treated with NA before infection with amphotropic pseudotypes. One-cycle infection with virions bearing the amphotropic murine leukemia virus (A-MLV) envelope glycoprotein was also found to be positively affected by NA (data not shown). Previous data suggest that vesicular stomatitis virus envelope glycop-rotein G (VSV-G) pseudotypes enter target cells using another pathway, i.e., via receptor-mediated endocytosis (Matlin et al., 1982) . To examine if the NA-induced enhancement of virus infectivity is affected by the entry pathway, the infectivity of VSV-G pseudotyped HIV-1 particles was assessed when using as targets either untreated or NA-treated Jurkat cells. As shown in Fig. 5D , pretreatment of Jurkat cells with NA led to an increase in virus infectivity. Altogether these data indicate that the noticed NA-dependent increase in virus infectivity is neither dependent on the nature of the cellular receptor(s) nor on the route of virus entry.
To more closely parallel physiological conditions, similar experiments were carried out using mitogen-stimulated PBMCs from three healthy donors as targets. Interestingly, enhanced infection with both T-and macrophage-tropic isolates of HIV-1 was detected in all donors tested following NA treatment (Figs. 6A and 6B).
The NA-mediated potentiating effect on virus infection is due to an increase of HIV-1 attachment and entry
Next we defined which step in the virus replicative cycle was affected by the enzyme treatment. Considering that the virus attachment/entry process might be one of the most likely targeted steps by NA, we addressed this possibility in the current work by performing virus binding and entry assays. Virus attachment was monitored by incubating Jurkat cells at 37°C in the absence or the presence of NA before allowing virus adsorption to the cell surface at 4°C. Next, the enzyme and unbound virions were removed by extensive washings of the cells FIG. 4 . Desialylation of gp120-expressing cells and an uninfected fusion partner contributes to the overall NA-mediated increase in cellto-cell conjugate formation. Cells were first pretreated or not with Arthrobacter-derived NA (0.01 U/ml) for 1 h at 37°C before being washed entensively to remove the enzyme. 1G5 were either incubated alone or in the presence of J1.1 cells for 16 h at 37°C. Finally, cells were lysed and luciferase activity was measured with a microplate luminometer. Presented results shown are the means Ϯ SD of samples performed in quadruplicate.
FIG. 3.
Interaction between gp120 and CD4/chemokine coreceptor is required for NA-induced upregulation of HIV-1-dependent syncytium formation. 1G5 and J1.1 cells were cocultured at a 2:1 ratio in the absence or presence of Arthrobacter-derived NA (0.01 U/ml) for 16 h at 37°C. Coincubation was also performed in the presence of SIM.2 (20 g/ml), an anti-CD4 antibody known to block the interaction between CD4 and gp120, or SDF-1 (10 g/ml), the natural ligand of CXCR4. Next, cells were lysed and luciferase activity was measured with a microplate luminometer. Presented results are the means Ϯ SD of samples performed in quadruplicate. and the levels of virions attached to the cell surface were estimated by a p24 assay. As depicted in Table 1 , treatment of Jurkat cells with Arthrobacter-derived NA resulted in an almost twofold increase in viral p24 associated to the cell surface (compare 2646.3 and 1428.3 pg of p24).
The putative modulatory effect of NA on the process of virus entry was next investigated. First, Jurkat cells treated or not with NA were inoculated with HIV-1 particles at 37°C to permit virus entry and noninternalized virions were subsequently eliminated by a treatment with proteolytic enzymes (i.e., pronase) using a previously described protocol (Maré chal et al., 1998; Paquette et al., 1998) . As shown in Table 1 , NA exerted a significant positive effect on viral p24 entry into Jurkat cells. Indeed, a 5-fold increase in internalized p24 was seen upon treatment with NA (compare 576.6 with 113.3 pg of p24). The overall percentage of viral p24 entry was estimated by dividing the level of intracellular p24 content by the total p24 content bound to the cells. Data showed that 21.8% of total viral p24 protein attaching to the NA-treated cells were taken up by cells, compared to only 8% for cells not treated with Arthrobacter-derived NA. It is important to specify that this 2.7-fold increment for the percentage of viral p24 entry upon enzyme treatment is comparable to the increment seen when NA-treated Jurkat cells were inoculated with luciferase-encoding cell-free virions (Fig. 5A) . Thus, these results indicate that HIV-1 attachment and entry seem to be the principal targets of NA action. were treated or not with Arthrobacter-derived NA (0.01 U/ml) for 1 h at 37°C. NA-treated cells were extensively washed before being incubated in the presence of progeny viruses. Virions were allowed to bind to either untreated or treated target cells (1 h at 4°C) and the virus/cell mixture was extensively washed to remove unbound virions and/or the enzyme. Cells were next incubated for 48 h at 37°C and virus-encoded luciferase activity was evaluated by using a luminometer device. Monocytic Mono Mac 1 cells (1 ϫ 10 5 ) were treated or not with Arthrobacter-derived NA (0.01 U/ml) for 30, 60, or 120 min at 37°C before being extensively washed to remove the enzyme. Cells were next inoculated with HXB-LUC particles (B) or luciferase-encoding virions pseudotyped with the envelope proteins from the macrophage-tropic viral strain BaL (C) (10 ng of p24). Cells were incubated for 48 h at 37°C and luciferase activity was assessed. Jurkat T cells (1 ϫ 10 5 ) were first treated or not with Arthrobacter-derived NA (0.01 U/ml) for 60 min at 37°C, then NA was removed by washing cells with PBS. Cells were subsequently incubated with VSV-G pseudotyped virions (5 ng of p24) for 120 min at 37°C before being extensively washed to remove unbound virions (D). Cells were incubated for 48 h at 37°C and luciferase activity was assessed. Presented results are the means Ϯ SD of samples performed in quadruplicate.
DISCUSSION
In this report, we have shown that treatment of human T cells with NA from a bacterial source (i.e., Arthrobacter) remarkably augmented the initial virus-induced cell-tocell and virus-cell interactions, thereby promoting both HIV-1-mediated giant cell formation and virus replication. The finding that heat-inactivation of the enzyme abolished its modulatory role is a clear indication that the noticed upregulating effect was due to the specific NA action.
The precise mechanism(s) responsible for the observed enhancement of HIV-1-dependent cytopathicity and virus infection by NA treatment is still undefined. However, a possible scenario could be a modulation of HIV-1-mediated syncytium formation and the process of virus infection through the removal of sialic acid moieties from both virion and cell surfaces. Sialic acid is one of the few sugars bearing a negative charge that exists at the nonreducing terminal of glycoconjugates. Thus, re-moval of sialic acid residues would significantly reduce the net negative charge on the surface of viruses and target cells, lowering the threshold binding energy required to overcome the repulsive electrostatic forces between viral and cellular membranes. The observation that infectivity of A-MLV-and VSV-G-bearing HIV-1 particles was also augmented upon NA treatment supports the idea that the mechanism of action of NA is probably not highly specific.
There is no doubt that the initial interactions between virally infected cells/cell-free virions and target cells are crucial for multinucleated cell formation and virus entry, two processes similarly relying on the close interaction between gp120 and CD4. Most cell types that are permissible for HIV-1 infection express little CD4 and the binding of virion-associated gp120 to cellular CD4 is often weak. Although a single gp120-CD4 interaction might be sufficient to lead to viral binding, numerous gp120-CD4 interactions are known to be required to achieve virus adsorption and penetration (Layne et al., 1990) . Interestingly, it has been suggested that spontaneous shedding of gp120 in vitro, which is linked to a loss of infectivity (McKeating et al., 1991) , is also occurring in vivo (Gelderblom et al., 1985) . Changes in infectivity have dramatic consequences in viral output. For example, a 50% reduction in infectivity will diminish the viral production to 0.0032% of the expected output after only five replicative cycles (Dimitrov et al., 1993) . Moreover, it is now becoming clear that supplementary interactions via receptors other than CD4 could dominate the initial attachment of HIV-1 to its target (Ugolini et al., 1999) . Syncytium formation is recognized as a more complex process than virus-cell fusion (Hernandez et al., 1996) , and it is thus likely that NA is affecting more interactions in this case than in HIV-1 attachment/entry step. It can thus be proposed that NA could also posi- a The amounts of virions entering the cells were determined by counting levels of viral p24 protein following lysis of pronase-treated infected cells. b Percentage of virus entry was determined by dividing the p24 content after pronase digestion by the total p24 content in the absence of pronase.
c Results shown are the means for quadruplicate samples and are representative of three independent experiments. Standard deviations were always lower than 10 percent.
FIG. 6. NA-mediated potentiating effect on single-round virus infection is also seen in human peripheral blood mononuclear cells. PBMCs from three healthy donors (1 ϫ 10 5 ) were first treated or not with Arthrobacter-derived NA (0.01 U/ml) for 1 h at 37°C. Cells were extensively washed to remove the enzyme before being inoculated with HXB-LUC particles (A) or luciferase-encoding virions pseudotyped with the envelope proteins from the macrophage-tropic viral strain BaL (B) (10 ng of p24). Infection was allowed to proceed for 72 h at 37°C and cells were lysed to monitor luciferase activity. Presented results are the means Ϯ SD for quadruplicate samples. tively influence these other additional secondary interactions between gp120-expressing cells/virions and susceptible cells.
Previous investigators have analyzed the possible effect of desialylation on replication of fully competent HIV-1 particles (Hu et al., 1996; Stamatos et al., 1997) . In these studies, HIV-1-mediated syncytium formation was assessed by microscopic evaluation several days after the initial infection. The noticed increase of HIV-1-induced cell fusion events was most likely attributable to an enhancement of virus replication in susceptible cells rather than a direct effect of NA on the initial fusion process between chronically HIV-1-infected cells and healthy permissive cells. In the present study, HIV-1mediated syncytium formation was rapidly assayed in a quantitative manner using a test system relying on transfer of the potent transactivating viral Tat protein from one chronically HIV-1-infected cell partner to another CD4 ϩ T cell line transiently or stably transfected with an HIV-1 LTR-driven reporter gene construct. Using this assay, we have been able to investigate the modulatory role of bacterial-derived NA on HIV-1-dependent cell-to-cell conjugate formation in a more sensitive and defined manner. We observed that NA treatment markedly enhanced virus-mediated syncytium formation in a timeand dose-dependent manner. Our data with the quantitative luciferase-based syncytium assay were consistent with microscopic visual observation, since treatment with NA resulted in a higher frequency of cell-to-cell interaction, as judged by a more extensive cellular aggregation, and in a dramatic increase in the number of HIV-1-induced syncytia. Our findings also indicate that both chronically HIV-1-infected cells and uninfected susceptible cells are targeted by NA action, as pretreatment of each individual cell partner led to a comparable induction of syncytium formation.
The finding that desialylated HIV-1 particles are more infectious than untreated virions is in agreement with a previous report (Hu et al., 1996) . The observation that pretreatment of susceptible cells did not significantly alter the process of virus infection led that group to postulate that viruses were the primary target of NA action. However, in contrast to that study, we found that treatment of target cells with NA renders them more susceptible to HIV-1 infection, allowing us to conclude that both HIV-1 particles and susceptible cells are the targets of NA action. This observation is in line with our own results with respect to NA-dependent upregulation of HIV-1-mediated syncytium formation. Additional studies are required to elucidate such a discrepancy, but it is quite possible that it might be attributable to differences in the experimental setting. For example, their experiments were performed with MT-4 cells, while we have made use of Jurkat cells as targets. MT-4 cells are expressing much higher levels of surface CD4 compared to Jurkat cells (unpublished observations). Consequently, the expected more numerous interactions between virion-associated gp120 and CD4 seen with MT-4 cells will permit them to more potently overcome the natural repulsive electrostatic forces. The final net result will be that NA treatment of cells such as MT-4 will have a minor effect on the process of HIV-1 infection. The degree of sialylation for cells expressing much lower amounts of surface CD4 (e.g., Jurkat) will become an important determinant, as NA-mediated desialylation will help to compensate for the suboptimal number of gp120-CD4 interactions occurring at the cell surface. Our results fully support this concept, since NA treatment of Sup-T1, a cell line known to express considerable amounts of CD4 (Bé rubé et al., 1996) , led to a slight 1.5-to 1.8-fold increase in single-round HIV-1 infection (data not shown), whereas a similar treatment of cells expressing much lower levels of surface CD4 (i.e., Jurkat and Mono Mac 1) resulted in a 2.8-to 5.5-fold increase in virus infection. It is also possible that the constitutive degree of sialylation of MT-4 cells is lower than, for example, Jurkat cells, which would account for their lesser susceptibility to NA action.
Although the experimental approach that was used in this study to assess virus entry does not permit discrimination between endocytosed versus cytosolic p24 (Maré chal et al., 1998) , our findings that the process of single-round HIV-1 infection was enhanced following NA treatment ( Figs. 5 and 6) is a clear indication that cytosolic p24 (an index of productive HIV-1 entry) is also increased in cells treated with NA.
In light of these results, we are proposing that dual infection with NA-bearing pathogens and HIV-1 might positively affect virus-mediated cytopathogenicity (i.e., syncytium formation) and viral replication, for example, in sites, such as secondary lymphoid organs, in which the probability of encountering these microorganisms is elevated. This hypothesis is based on the following reasons: first, in HIV-1-infected individuals, a heavy viral load and a large portion of chronically HIV-1-infected cells are present in the lymphoid organs, at every stage of the disease, making them the major viral reservoirs (Pantaleo et al., 1991) ; second, persons afflicted with this retroviral infection are more prone to acquire infections from other pathogens, some of which are producing NA as their virulence factors (Neuzil et al., 1999) ; third, peripheral lymphoid organs, especially the local lymph nodes, are the anatomic sites in which these pathogens are concentrated; fourth, and lastly, the finding that, in some severe microbial infections, blood cells are desialylated by pathogen-associated and -secreted NA is an indication that sialidases are still biologically effective under in vivo conditions (Roggentin et al., 1988 (Roggentin et al., , 1993 . However, it should be kept in mind that many opportunistic agents are localized to epithelial cells and that the probability of encountering secreted NA systemically is thus reduced. It can also be proposed that the effect of NA on nonproductively infected T cells (which thus express low gp120 levels on their surface), which account for the vast majority of infected T cells, will favor syncytium formation.
In summary, our data suggest that the degree of sialylation on both HIV-1 particles and target cells modulates the life cycle of HIV-1. Indeed, the removal of sialic acid residues by NA treatment promotes HIV-1-mediated syncytium formation and virus entry by directly increasing the interaction between virally infected cells/virions and target cells. Our observations have considerable physiological relevance, since patients harboring HIV-1 come frequently in contact with NA-bearing microorganisms.
MATERIALS AND METHODS

Cell lines and plasmids
All T cell lines were cultured in complete culture medium made of RPMI 1640 supplemented with 10% fetal bovine serum (FBS; GIBCO, BRL, Life Technologies, Inc., Gaithersburg, MD), glutamine (2 mM), penicillin G (100 U/ml), and streptomycin (100 g/ml) and were maintained at 37°C under a 5% CO 2 humid atmosphere. In the present study, we used the human established CD4 ϩ T cell lines 1G5, Sup-T1 (Smith et al., 1984) , and Jurkat E6.1 (Weiss et al., 1984) . The Jurkat E6.1 derivative 1G5 cell line carries two copies of a stably transfected plasmid made of the luciferase reporter gene placed downstream of the HIV-1 LTR regulatory region (Aguilar-Cordova et al., 1994) . Cell lines chronically infected with HIV-1 included J1.1, which is infected with HIV-1 LAI (Perez et al., 1991) , and H9, infected with HIV-1 IIIB , HIV-1 IIIMN , or HIV-1 IIIRF (Mann et al., 1989) . The Mono Mac 1 monocytic lineage was initially derived from the Mono Mac parental cell line, which was itself established from the peripheral blood of a patient diagnosed with an acute peripheral monoblastic leukemia (Steube et al., 1997) . The human monocytoid Mono Mac 1 cell line (available through the German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) was cultured in complete culture medium supplemented with 1ϫ MEM nonessential amino acids and sodium pyruvic acid (1 mM). 293T cells, expressing the simian virus 40 large T antigen, were kindly provided by Dr. W. C. Greene (The J. Gladstone Institutes, San Francisco, CA) and were maintained in DMEM supplemented with 10% FBS, L-glutamine (2 mM), penicillin G (100 U/ml), and streptomycin (100 g/ml). PBMCs from healthy donors were isolated by the Ficoll-Hypaque density gradient centrifugation and were cultured for 3 days in the presence of 3 g/ml PHA (Sigma Chemical Co., St. Louis, MO) and 30 U/ml recombinant human IL-2 (rhIL-2).
The pLTR-LUC plasmid (HIV-1 LTR from strain HXB2), obtained from Dr. K. L. Calame (Columbia University, NY), contains the luciferase reporter gene under the control of the wild-type HIV-1 LTR (Henderson et al., 1995) . The proviral plasmid pHXB-LUC, kindly provided by Dr. D. Baltimore (Massachusetts Institute of Technology, Cambridge, MA), was originally derived from pHXB-2D from which a part of the nef gene was deleted and replaced with the luciferase reporter gene (Chen et al., 1994) . The luciferase-containing NL4-3 backbone pNL4-3-LUC-E Ϫ R ϩ and pcDNA-I/Amp-based expression vectors coding for HIV-1 HXB2 (X4), HIV-1 BaL (R5), and A-MLV full-length envelope proteins were generously provided by Dr. N. R. Landau (The Salk Institute for Biological Studies, La Jolla, CA). The pHCMV-G expressing the broad-host-range VSV-G from the human cytomegalovirus (HCMV) promoter has been described previously (Yee et al., 1994) .
Neuraminidases, antibodies, and soluble proteins
A. ureafaciens-derived NA was purchased from Nacalai Tesque Inc. (Japan). SDF-1 was a kind gift from Dr. I. Clark-Lewis (Biomedical Research Center, Vancouver). The anti-CD4 SIM.2 antibody, a potent inhibitor of HIV-1mediated syncytium formation (Barbeau et al., 1998) , has been supplied by the AIDS Research and Reference Reagent Program (Division of AIDS, NIAID, NIH).
Syncytium assay
The luciferase-based quantitative syncytium assay was performed accoding to a previously described protocol (Barbeau et al., 1998) . Briefly, uninfected and HIV-1 chronically infected cells were concentrated to 2 ϫ 10 6 cells/ml and 1 ϫ 10 6 cells/ml, respectively. Then, 100 l of each cell suspension was mixed together and incubated at 37°C for the indicated time period in the absence or the presence of different concentrations of NA derived from Arthrobacter. In some experiments, cells were pretreated with 0.01 U/ml of NA for 1 h at 37°C. Next, cells were washed twice with ice-cold phosphate buffered saline (PBS), seeded, and mixed in 96-well tissue culture plates. After 16 h of incubation at 37°C, syncytia were first visualized and photographed at a magnification of 100ϫ with an inverted microscope before the removal of 100 l of cell-free supernatant from each well and the addition of 25 l of cell culture lysis buffer [125 mM triphosphate (pH 7.8), 10 mM dithiothreitol (DTT), 5% Triton x-100, 50% glycerol)]. After an incubation period of 30 min at room temperature, an aliquot of 20 l of lysate was then mixed with 100 l of luciferase assay buffer [210 mM tricine, 
DEAE-Dextran transfection
Cells (5 ϫ 10 6 ) were washed in TS buffer [137 mM NaCl, 25 mM Tris-HCl (pH 7.4), 5 mM KCl, 0.6 mM Na 2 HPO 4 , 0.5 mM MgCl 2 , and 0.7 mM CaCl 2 ] and then incubated along with pLTR-LUC (15 g) in 0.5 ml TS buffer containing 500 g/ml of DEAE-Dextran for 25 min at room temperature. Afterward, 5 ml of supplemented RPMI was added to the cells along with 100 M chloroquine, and cells were incubated at 37°C for 45 min. After pelleting, cells were resuspended in 5 ml of supplemented RPMI and incubated at 37°C for 24 h.
Production of virus stocks and virus infection
Viral particles were produced by CaPO 4 transfection of 293T cells with virus-encoding vectors as previously described Fortin et al., 1997) . Transfection of pNL4-3 or pHXB-LUC led to the production of virus stocks called NL4-3 and HXB-LUC. Pseudotyped HIV-1 particles were generated by cotransfection of 293T cells with pNL4-3-LUC-E Ϫ R ϩ and expression vectors coding for HIV-1 HXB2, HIV-1 BaL, A-MLV, and VSV-G full-length envelope proteins. Virus stocks were normalized for virion content using a commercial assay for the viral major core protein p24 (Organon Teknika, Durham, NC).
Infections were done using a fixed amount of virus (standardized in term of p24 protein) to inoculate 10 5 cells. Cells were first treated or not with 0.01 U of NA for 120 min at 37°C. Next, NA was eliminated by washing cells twice with PBS. Pelleted cells were resuspended in 200 l RPMI containing 5 to 10 ng of p24 for studied virus preparations (for PBMCs, the culture medium was supplemented with 30 U/ml of rhIL-2) and incubated at 37°C in 96-well tissue culture plates for the indicated time period. SIM.2 and SDF-1 were applied to the cell culture along with virus preparations to block the virus infection process. To address the NA-mediated specific effect on HIV-1, NA was first heat-inactivated (100°C for 10 min) before its use. In some experiments, either cells or virus stocks were pretreated with NA at 37°C for 1 h and the virus/cell mixture was incubated at 4°C for 1 h, an experimental condition that allows virus binding to target cells but minimizes NA activity. The virus/cell mixture was washed with ice-cold PBS and incubated at 37°C for the indicated time period. Finally, cells were lysed and luciferase activity was monitored as previously described (Paquette et al., 1998) .
HIV-1 attachment and entry assays
For each sample, Jurkat cells (5 ϫ 10 6 ) were either left untreated or treated with 0.1 U NA at 37°C for 2 h before being extensively washed with PBS to remove the enzyme. In some cases, cells were also incubated with soluble CD4 (sCD4) (5 g/ml) for 1 h at 4°C before being washed with PBS. Next, virions were allowed to adsorb to the cell surface by incubating cells at 4°C for 1 h with HIV-1 NL4-3 (100 ng of p24). Such cells were extensively washed to remove unbound viruses and enzyme and lysed in 200 l of disruption buffer (2.5% Triton X-100 in PBS). The amount of virus bound to cells was subsequently quantitated by p24 ELISA. For the entry assay, the virus/cell mixture was incubated at 37°C for 1 h, and the unadsorbed virions remaining on the cell surface were eliminated by a treatment with 0.1 mg/ml of pronase (Boehringer Mannheim, Laval, Quebec, Canada) for 5 min at 4°C. After extensive washes, cells were finally lysed and assayed for intracellular p24.
